Seed · Enterprise software

Pharosyn raises $3m seed for product development

Entrepreneurs First, Transpose Platform, General Advance and Moonfire Ventures backed the round.

Pharosyn plans to accelerate development of its commercial-intelligence tools for pharmaceutical companies.

The company reports a top-ten biopharma customer already using its system. Its congress-coverage workflow produces editable summary decks and source-linked follow-up analysis, providing an operating context for further development.

Use of funds

Accelerate product development and commercial decisions for pharmaceutical companies

Funding history

Seed · This round$3M

Sources

  1. Exclusive: London’s Pharosyn raises $3M to speed up pharma’s commercial decisions — TFNtechfundingnews.com · Sep 2, 2026
  2. pharosyn.ai